70 related articles for article (PubMed ID: 6821267)
1. [Factors affecting the results of determining hemagglutinin in inactivated influenza vaccines].
Popov VF; Bizhanov GI; Lonskaia NI; Kastrikina LN
Tr Inst Im Pastera; 1982; 59():96-8. PubMed ID: 6821267
[No Abstract] [Full Text] [Related]
2. [Determination of the quantitative hemagglutinin content in influenza vaccine by means of radial immunodiffusion].
Chubarova NI
Tr Inst Im Pastera; 1979; 52():128-32. PubMed ID: 121647
[No Abstract] [Full Text] [Related]
3. [Evaluation of a radial immunodiffusion method for the quantitative determination of influenza virus hemagglutinin].
Chubarova NI
Tr Inst Im Pastera; 1982; 59():94-6. PubMed ID: 6821266
[No Abstract] [Full Text] [Related]
4. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
Stech J
Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
[TBL] [Abstract][Full Text] [Related]
5. Single radial immunodiffusion potency test for standardization of indigenous equine influenza vaccine.
Gupta AK; Yadav MP; Uppal PK
Indian J Exp Biol; 1993 Dec; 31(12):944-7. PubMed ID: 8112772
[TBL] [Abstract][Full Text] [Related]
6. Influence of detergents on measurement of influenza A virus haemagglutinin content in inactivated influenza vaccine by single radial immunodiffusion.
Bizhanov GI; Kastrikina LN; Lonskaya NI; Popov VF
Acta Virol; 1988 May; 32(3):252-60. PubMed ID: 2902773
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis.
Mayner RE; Blackburn RJ; Barry DW
Dev Biol Stand; 1977 Jun 1-3; 39():169-78. PubMed ID: 414948
[TBL] [Abstract][Full Text] [Related]
8. [Improved methods of controlling the purity and activity of inactivated influenza vaccines].
Noskov FS; Bichurina MA; Zhebrun AB; Polianskaia NIu; Kaplun IIa
Vopr Virusol; 1985; 30(4):409-13. PubMed ID: 3933181
[TBL] [Abstract][Full Text] [Related]
9. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines.
Schild GC; Wood JM; Newman RW
Bull World Health Organ; 1975; 52(2):223-31. PubMed ID: 816480
[TBL] [Abstract][Full Text] [Related]
10. [Neuraminidase activity of inactivated influenza vaccines].
Buchowicz I; Wrzos H; Filczak K; Bańkowski A; Korbecki M
Med Dosw Mikrobiol; 1979; 31(2):103-10. PubMed ID: 502643
[No Abstract] [Full Text] [Related]
11. Free haemagglutinin in inactivated whole virus influenza vaccines.
Kastrikina LN; Minaev VI; Lonskaya NI; Bizhanov GI
Biologicals; 1990 Jan; 18(1):39-43. PubMed ID: 2107828
[TBL] [Abstract][Full Text] [Related]
12. The assay of haemagglutinin antigen content of split influenza vaccine by immunochemical methods.
Anghel C; Creţescu L; Botez D
Arch Roum Pathol Exp Microbiol; 1981; 40(3):259-64. PubMed ID: 6800342
[No Abstract] [Full Text] [Related]
13. [Testing of influenza virus vaccines--an international comparison].
Klett G; Stäber H; Willkommen H
Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
[No Abstract] [Full Text] [Related]
14. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines.
Wood JM; Schild GC; Newman RW; Seagroatt V
J Biol Stand; 1977; 5(3):237-47. PubMed ID: 408355
[No Abstract] [Full Text] [Related]
15. [Stability of inactivated influenza vaccine during storage].
Kastrikina LN; Bizhanov LN; Lonskaia NI; Popov VF
Vopr Virusol; 1990; 35(1):68-70. PubMed ID: 2114055
[No Abstract] [Full Text] [Related]
16. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
17. [Properties and biological activity of inactivated influenza vaccine].
D'iachenko AP
Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
[No Abstract] [Full Text] [Related]
18. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review.
Boyce TG; Poland GA
Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719
[TBL] [Abstract][Full Text] [Related]
19. Quantification of haemagglutinin of influenza Tween-ether split vaccines by immunodiffusion.
Johannsen R; Moser H; Hinz J; Friesen HJ; Gruschkau H
Vaccine; 1985 Sep; 3(3 Suppl):235-40. PubMed ID: 3933204
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
